Icon partners with Anthropic to integrate Claude AI into clinical trial planning
Icon, a contract research organization, announced a multi-year collaboration with Anthropic to bring the Claude AI system into its clinical trial operations.
The partnership will combine Anthropic’s Life Sciences research team with Icon’s AI platform, Orbis, to enhance tools such as OneSearch and OnePlan, aiming to improve site selection, feasibility assessments, and real-time enrollment risk detection.
Anthropic’s regional head noted that operational bottlenecks like enrollment delays affect up to 80% of trials, and the combined expertise is intended to speed medicine delivery.
The collaboration also plans to embed Claude across Icon’s organization, including a Claude Code offering for development, allowing clients to tap into Icon’s trial insights through the AI.
This writeup was produced by pharmadog from original reporting by Fierce Biotech.
Original headline: “Icon inks Anthropic partnership to deploy Claude into clinical trials”
read at Fierce Biotech ↗
comments(0)
5-min edit window · permanent after that